VitroGel® Hydrogel for In Vivo / Tissue Engineering Revolutionizing Cartilage Repair: Combining the VitroGel® System with a Bendable-Tip Arthroscopic Device for Controlled Hydrogel Extrusion
Author Archives: Kyra Baricaua
VitroGel® RGD played a key role in preserving tumor architecture for effective drug testing in lymphoma research Institutions: Swiss Institute for Experimental Cancer Research, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Team: Albert Santamaria-Martínez, Justine Epiney, Divyanshu Srivastava, Daniele Tavernari, Marco Varrone, Dina Milowich, Igor Letovanec, Thorsten Krueger, Rafael Duran, Giovanni Ciriello, Anne […]
VitroGel® significantly enhanced the delivery of dexamethasone to the inner ear, providing controlled release and improved protection against cisplatin-induced hearing loss. Institutions:“Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania Team:Maximilian G. Dindelegan, Cristina M. Blebea, Maria Perde-Schrepler, Violeta Necula, Alma A. Maniu, Violeta Pascalau, Catalin Popa, Sergiu Susman, Luciana M. Gherman, Anca D. […]
VitroGel® revolutionizes colorectal cancer research by creating a xeno-free platform for patient-derived organoids, enabling groundbreaking insights into tumor-immune interactions and immunotherapy responses. Institutions:Fondazione Policlinico A. Gemelli IRCCS, Rome Team:Alice Dini, Harlan Carmine Carbone, Annachiara Esposito, Antonio Agostini, Giuseppe Quero, Geny Piro, Lorenzo Priori, Alessia Caggiano, Giulia Scaglione, Alessandra Battaglia, Maria Calegari, Lisa Salvatore, Maria […]
VitroGel® ORGANOID empowered breakthrough single-cell pharmacotranscriptomic profiling by enabling robust, patient-specific cancer organoid models for drug discovery and resistance analysis. Institutions: Disease Networks Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. Team: Alice Dini, Harlan Barker, Emilia Piki, Subodh Sharma, Juuli Raivola, Astrid Murumägi & Daniela Ungureanu. Category: Organoids Subcategory/cell […]
VitroGel® ORGANOID-4 deepened ovarian cancer research by allowing 3D spheroid formation and transcriptomic analysis, identifying key signaling STAT1 and GREM1 activation pathways. Institutions:University of Oulu; Institute for Molecular Medicine Finland; University of Helsinki; Tampere University Hospital and Faculty of Medicine and Health Technology; Okayama University Graduate School of Medicine; Karolinska Institutet. Team:Emilia Piki, Alice Dini, […]
VitroGel® Hydrogel for Ex Vivo/Tissue Explant Models Lymphomoids: A Tissue-based Ex Vivo Culture System for Lymphoma Therapy Screening
2024 in Review: TheWell Bioscience Milestones, Growth, and Vision for 2025 We’re excited to celebrate the milestones that defined this remarkable year. We extend our heartfelt gratitude to all the researchers, collaborators, and partners who have supported us in advancing VitroGel® for 3D cell culture, driving innovation in biomedicine and beyond.
2024 Innovations for Advancing 3D Cell Culture This year has marked remarkable growth and innovation for TheWell Bioscience. We introduced groundbreaking products, including the VitroGel® Invasion Assay Kits, VitroGel® Starter Kits, VitroPrime Cell Culture Inserts, and VitroPrime Spread-Attach Plate. These innovations further enhance our comprehensive workflow for full lab automation, empowering researchers to achieve greater […]
VitroGel® Hydrogel Matrix provided a realistic three-dimensional environment for studying Glioblastoma invasion behavior. Institution:Department of Biological Science, Chungnam National University Team:Jiyoon Baik, Myunghoon Lee, Jae Hong Yoo, Ahyeon Jo, Kyung-Seok Han Category:3D Cell Models & Functional Assay Subcategory/cell type:Invasion assay/U-87MG Glioblastoma Cells Hydrogel:VitroGel® Hydrogel Matrix (Cat. No: VHM01) Glioblastoma (GBM) is a highly aggressive brain cancer known for its invasive nature, […]
- 1
- 2
